Formaldehyde
CAS 50-00-0
Formaldehyde (CAS 50-00-0) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 500 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| TRPA1 Trpa1 |
Activation | 3.4000000953674316 pEC50 | 17686976|17942735 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| FORMALDEHYDE | 4530 | SU | MTHSPL |
| formaldehyde | 4530 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Formaldehyde used for in pharmaceutical contexts?
Formaldehyde (CAS 50-00-0) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Formaldehyde?
No adverse-event association or SIDER side-effect rows are rendered for Formaldehyde in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Formaldehyde also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for Formaldehyde.
What clinical phase is Formaldehyde in?
No phase 1-4 clinical development badge is rendered for Formaldehyde because the matched compound identifier rows do not contain a max-phase value.